Immucor Inc – ‘10-K405’ for 5/31/99 – EX-21

On:  Monday, 8/30/99   ·   For:  5/31/99   ·   Accession #:  736822-99-29   ·   File #:  0-14820

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Annual Report — [x] Reg. S-K Item 405   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K405     10K 5/31/99                                           73±   350K 
 3: EX-10       Employment Agreements                                 41±   166K 
 2: EX-10.1-5   Building Lease Amendment                               6±    25K 
 4: EX-10.24    First Modification of Loan Agreement                   5±    25K 
 5: EX-21       Subs of Registrant                                     1      4K 
 6: EX-23       Consent                                                1      7K 
 7: EX-27       FDS--FY 99                                             1      6K 

EX-21   —   Subs of Registrant

EXHIBIT 21                                                                      

Subsidiaries of Registrant

Subsidiary                                       Jurisdiction of Organization   
----------------------------                     ----------------------------   
Immucor GmbH                                     Federal Republic of Germany    

Immucor Italia Srl                               Italy                          

Immucor Portugal, Lda.                           Portugal                       

Immucor, S.L.                                    Spain                          

Dominion Biologicals Limited                     Canada                         

Gamma Biologicals, Inc.                          United States                  

Gamma BV                                         Netherlands                    

Medichim S.A.                                    Belgium                        

Immunochim s.a.r.l.                              France                         

The Company owns 100% of the outstanding stock of each of the above.